← Back to front page
United States · Exchanges & live quotes · Nasdaq

Zealand Pharma Wins EU Approval For Zeydovio To Treat Short Bowel Syndrome

Published by Nasdaq · United States 52 min ago

Detailed summary

(RTTNews) - Zealand Pharma A/S (ZLDPF.PK, ZEAL.CO), a biotechnology company focused on metabolic health, announced Friday that the European Commission has granted marketing…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading